Request page removalAbout Andrew Adams
Andrew Adams is an angel investor, an entrepreneur and a board member based out of United States. They did their education from Stanford University. Their journey in the startup ecosystem started in 2012 through Headway. Andrew Adams has founded 1 company. They are currently acting as the, and as the co-founder of Headway. As an angel investor, Andrew Adams has a portfolio of 2 companies, focusing primarily on sectors like FinTech and Healthcare. They invest in companies across United States and Iceland. Their most notable investments are Brellium and Finni Health. Andrew Adams is currently serving as a board member at Headway and Reveleer, which they founded.
Key Metrics
Location
Founded
Investment Portfolio
Top sectors of Investment
Top locations of Investment
Contact Details
Andrew Adams' Investments
Andrew Adams has invested in 2 companies. Their most recent investment was in Brellium (Series A Round) on Apr 17, 2025. Their investments are primarily in FinTech and Healthcare. Their investment portfolio include companies in United States and Iceland.Here are the details of all recent investments by Andrew Adams:
Date | Company | Round | Round Amount | Co-Investors |
|---|---|---|---|---|
Apr 17, 2025 | Series A | $16.7M | ||
Jun 12, 2023 | Seed | $3.2M |
Want to explore profiles similar to Andrew Adams?
Let us walk you through our investor database and other offerings.
Let us walk you through our investor database and other offerings.
Andrew Adams' Founded Companies
Andrew Adams has founded Headway.
Here is the detail of this founded company:
Company | Short Description | Total Funding | Founded Year | Current Stage | Location |
|---|---|---|---|---|---|
Provider of a mental health therapist consultation platform | $321M | 2012 | Series D | New York City |
Andrew Adams' Board Memberships
Andrew Adams has 2 current board memberships namely Headway and Reveleer.Here are the details of all board memberships by Andrew Adams:
Company | Description | Total Funding | Current Stage | Membership Status | Appointment Date | Cessation Date |
|---|---|---|---|---|---|---|
Provider of a mental health therapist consultation platform | $321M | Series D | CURRENT | Jul 31, 2024 | - | |
AI-powered software platform for value-based healthcare | $162M | Series E | CURRENT | Apr 19, 2022 | - |
FAQs about Andrew Adams
Recently updated other profiles
